The potential role of ADCY5 in colorectal cancer prognosis is underscored by its methylation status and expression patterns observed in both type 2 diabetes mellitus (T2DM) (Wei et al., 2022) and glioblastoma studies (Can et al., 2024). This evidence concerns the gene ADCY5 and glioblastoma.